Implementation and Evaluation of A Health Innovation to Support Medicaid-Insured Individuals Following Hospitalization

Sponsor
University of Pennsylvania (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05714605
Collaborator
Rita & Alex Hillman Foundation (Other)
267
2
22.1

Study Details

Study Description

Brief Summary

The goal of this stepped wedge pragmatic trial is to compare referral patterns and post discharge outcomes in Medicaid insured individuals discharge following a hospitalization]. The aims are to 1) evaluate the implementation of the THRIVE clinical pathway, including feasibility, appropriateness, and acceptability and 2) examine referral patterns, 30- day readmission and ED utilization patterns for participants who receive THRIVE support services. During hospitalization participants will receive a referral to home care services and will be seen by a home care nurse within 48 hours following discharge. A discharging physician or Advanced Practice Provider will maintain clinical oversight for 30 days or until the patient sees primary care provider or specialist. A Care Coordination Team conducts weekly case conferences to ensure social and health needs are being addressed for 30 days post-discharge. Researchers will compare Medicaid insured patients discharged during the study, to those receiving usual care to determine if there are differences in post-acute utilization outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: THRIVE Intervention
N/A

Detailed Description

This is a prospective single site Type 1 hybrid effectiveness-implementation parallel mixed methods (QUANT + qual) quasi-experimental study. This study design involves simultaneous collection and analysis of quantitative and qualitative data, giving priority weight to the quantitative data to evaluate program referrals, outcomes, and program fidelity, while qualitative data will evaluate process through detailed descriptions of perspectives of barriers and facilitators faced by health care providers in implementing the THRIVE intervention. Qualitative interviews will also assess stakeholder perspectives of the value of the intervention in addressing health inequities among Medicaid insured individuals cared for in the acute and home care settings. Nesting the qualitative interview within a single-site randomized trial of a the THRIVE intervention will allow us to determine whether the intervention improved primary outcomes (referrals to homecare, 30-day readmission, ED utilization, connection to PCP) and to identify professional and organizational barriers to implementation. Combining these insights with that of effectiveness outcome date will allow consideration for meaningful contextual factors that are viewed as critical to the implementation of THRIVE and subsequent outcomes. Our stepped wedge design with include a randomized roll-out to case managers at Pennsylvania Hospital and the study will be carried out over 18 months. To begin, 5 case managers will be randomized to receive training on the THRIVE clinical pathway. Following training they will be invited to begin offering referrals to the THRIVE clinical pathway. After 2 months the remaining 4 case managers will be trained on the THRIVE intervention and will be able to begin submitting referrals.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
267 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Implementation and Evaluation of THRIVE: A Health Innovation to Support Care Transitions for Medicaid-Insured Individuals Following Hospitalization
Anticipated Study Start Date :
Feb 27, 2023
Anticipated Primary Completion Date :
May 27, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: THRIVE Intervention

1 month intensive post discharge case management and care coordination.

Behavioral: THRIVE Intervention
The THRIVE Clinical Pathway is a standardized transitional care clinical pathway that supports Medicaid insured or Medicaid eligible individuals following hospitalization.

No Intervention: Usual Care

Discharge to home without intensive post acute case management or care coordination.

Outcome Measures

Primary Outcome Measures

  1. Rates of Referrals to Homecare [Through study completion, an average of 18 months]

    We will evaluate changes in home care referrals between case managers exposed to the intervention compared to those who were not.

  2. Rates of Readmissions [30 days following hospital discharge]

    We will evaluate the rate of readmissions over the course of the study for THRIVE participants compared to those receiving usual care.

  3. Rates of Emergency Department Visit [30 days following hospital discharge]

    We will evaluate the rate of ED visits over the course of the study for THRIVE participants compared to those receiving usual care.

  4. Primary Care or Specialist Visit [30 Days following hospital discharge]

    We will compare the rates of primary care provider and specialist visits within 30 days following discharge compared to those receiving usual care.

Secondary Outcome Measures

  1. Feasibility, Acceptability, Appropriateness, Workload [Through study completion, an average of 18 months]

    We will conduct interviews of clinicians at the conclusion of the study to gather perceptions of the THRIVE clinical pathway and facilitators and barriers to engaging with the intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Medicaid insured

  • Residing in the state of Pennsylvania

  • Experienced a hospitalization at study hospital

  • Agrees to home care at partner home care setting.

Exclusion Criteria:
  • Individuals under age 18

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Pennsylvania
  • Rita & Alex Hillman Foundation

Investigators

  • Principal Investigator: Margo B Brooks Carthon, PhD RN, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05714605
Other Study ID Numbers:
  • 10080229
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 6, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 6, 2023